Oak hill bio - Crunchbase Company Profile & Funding

Q: Who invested in Oak hill bio?

Oak hill bio has 4 investors including Balyasny Asset Management And Janus Henderson Investors.

Q: When was the last funding round for Oak hill bio?

Oak hill bio closed its last funding round on obfuscated from a Series A round.

Q: How much funding has Oak hill bio raised to date?

Oak hill bio has raised obfuscated.

Overview

Oak hill bio

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Events

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

+3 more milestones

See more interactive data and historical milestones on desktop for the best experience

About Oak hill bio

CB Rank

4336

Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.

Founded

obfuscation

Private

Series A

Altrincham, Cheshire, United Kingdom

11-50

www.oakhillbio.com

Biotechnology

Health Care

Funding Rounds

Series A

OBF

obfuscation

Key People

Mark McHale: Chief Scientific Officer
Past Role: TheraMyc, Chief Operating Officer
Josh Distler: Co-Founder
Past Role: Oak hill bio, President, and CFO

Details

Legal Name

Oak Hill Bio Holdings Ltd.

Operating Status

Active

Company Type

For Profit

About the Company

Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.

Phone Number

+44 1865 966499

Contact Email

info@oakhillbio.com

Predictions & Insights

Growth Insight

See this Growth Insight

Oak hill bio is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Key Employee Changes

Products & Services

Rugonersen

An RNA antisense oligonucleotide designed to unsilence the paternal UBE3A gene in neurons to address Angelman syndrome.

OHB-607

A recombinant human IGF-1/IGFBP-3 therapy intended to support organ development and prevent complications in extremely premature infants.

Research & Development

Oak hill bio is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - Oak hill bio	4	obfuscated obfuscation	Balyasny Asset Management, Janus Henderson Investors, venBio Partners	Series A
obfuscated obfuscation	Series A - Oak hill bio	4	obfuscated obfuscation	Balyasny Asset Management, Janus Henderson Investors, venBio Partners	Series A
obfuscated obfuscation	Series A - Oak hill bio	4	obfuscated obfuscation	Balyasny Asset Management, Janus Henderson Investors, venBio Partners	Series A
obfuscated obfuscation	Series A - Oak hill bio	4	obfuscated obfuscation	Balyasny Asset Management, Janus Henderson Investors, venBio Partners	Series A
obfuscated obfuscation	Series A - Oak hill bio	4	obfuscated obfuscation	Balyasny Asset Management, Janus Henderson Investors, venBio Partners	Series A

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - Oak hill bio	4	obfuscated obfuscation	Balyasny Asset Management, Janus Henderson Investors, venBio Partners	Series A
obfuscated obfuscation	Series A - Oak hill bio	4	obfuscated obfuscation	Balyasny Asset Management, Janus Henderson Investors, venBio Partners	Series A
obfuscated obfuscation	Series A - Oak hill bio	4	obfuscated obfuscation	Balyasny Asset Management, Janus Henderson Investors, venBio Partners	Series A
obfuscated obfuscation	Series A - Oak hill bio	4	obfuscated obfuscation	Balyasny Asset Management, Janus Henderson Investors, venBio Partners	Series A
obfuscated obfuscation	Series A - Oak hill bio	4	obfuscated obfuscation	Balyasny Asset Management, Janus Henderson Investors, venBio Partners	Series A

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Balyasny Asset Management	Yes	Series A - Oak hill bio	—
Balyasny Asset Management	Yes	Series A - Oak hill bio	—
Balyasny Asset Management	Yes	Series A - Oak hill bio	—
Balyasny Asset Management	Yes	Series A - Oak hill bio	—
Balyasny Asset Management	Yes	Series A - Oak hill bio	—